Clinical Trial Update: Amniotic Fluid Mesenchymal Stem Cells Developed for Chondrogenic Treatment (AFCC) Injection in Elderly Knee Osteoarthritis Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating injections of amniotic fluid-derived mesenchymal stem cells (AFCC) for chondrogenic treatment in knee osteoarthritis is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• AFCC Injection (amniotic fluid-derived mesenchymal stem cells)

Snippet

Sponsor: Siriraj Hospital | Conditions: Knee Osteoarthritis | Phase 1 | Status: ENROLLING_BY_INVITATION